Sheila Connelly (S Connelly)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Antimicrobial Resistance

Microbial Community

Clostridium Difficile

Top Venues

Science advances

Infection and drug resistance

Journal of applied microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Annalee W Nguyen, Andrea M DiVenere, James F Papin, Sheila Connelly, Michael Kaleko, Jennifer A Maynard
Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons. Science advances 6 (6) (2020)
John F Kokai-Kun, Chenxiong Le, Kenneth Trout, Julia L Cope, Nadim J Ajami, Andrew J Degar, Sheila Connelly
Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone. Infection and drug resistance 13 (2020)
Sheila Connelly, Brian Fanelli, Nur A Hasan, Rita R Colwell, Michael Kaleko
Oral Beta-Lactamase Protects the Canine Gut Microbiome from Oral Amoxicillin-Mediated Damage. Microorganisms 7 (5) (2019)
Sheila Connelly, Todd Parsley, Hui Ge, Michael Kaleko
Identification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut Dysbiosis. Microorganisms 7 (1) (2019)
Sheila Connelly, J A Bristol, S Hubert, P Subramanian, N A Hasan, R R Colwell, M Kaleko
SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model. Journal of applied microbiology 123 (1) (2017)